ParkerVision's Legal Battle Against Qualcomm: Potential Multi-Billion Dollar Damages and Investment Risks Analyzed
ParkerVision is engaged in a legal battle with Qualcomm over alleged patent infringement of radiofrequency technology.
Key Updates on EPIX, HLVX, PRKR, BOOM, VZIO, WOW, AVAP:L, LOGC, LFCR, DK
Essa Pharma (EPIX) halted pipeline development, launched strategic review, offering 21% upside to NAV/liquidation value by mid-2025.
No more insights